Fresenius Medical Center Brooklyn, NY - 11201

Fresenius Medical Center is categorized under Kidney Dialysis Centers in Brooklyn, NY .

Fresenius Medical Center was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214920 by the NAICS.

If you are seeking more information, feel free to contact Alicia Calderon, Administrator at the company’s single location by writing to 339 Hicks St, Brooklyn, New York NY 11201 or by phoning (718) 780-1224. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Fresenius Medical Center
Contact Person: Alicia Calderon, Administrator
Address: 339 Hicks St, Brooklyn, New York 11201
Phone Number: (718) 780-1224
Website Address: fresenius.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 6214920
Share This Business:

Fresenius Medical Center was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Alicia Calderon, Administrator for inquiries that concern Fresenius Medical Center by calling the company number (718) 780-1224, as your correspondence is most welcome. Additionally, the physical location of the single location of Fresenius Medical Center can be found at the coordinates 40.69101,-73.9978 as well as the street address 339 Hicks St in Brooklyn, New York 11201.

For its online presence, you may visit Fresenius Medical Center’s website at fresenius.com and engage with its social media outlets through on Twitter and on Facebook.